Faeth Therapeutics Gets FDA Fast Track for PIKTOR in Advanced Endometrial Cancer

Faeth Therapeutics receives FDA Fast Track for PIKTOR + paclitaxel in advanced endometrial cancer with PI3K pathway changes. Phase 2 data expected end-2026.